Showing results (581-590 of 942) with videos related to
Sort By:
Pageof 95
Neurology and Therapy|April 11, 2026
Patient- and Caregiver-Reported Burden and Quality of Life in Generalised Myasthenia Gravis: A Multinational Real-World Survey in the Asia-Pacific RegionDaeYoung Yu, Mami Kasahara-Kiritani, Bolam Lee, et al.Neurology and Therapy|April 11, 2026
Artificial Intelligence and Machine Learning in Pediatric Epilepsy: A Systematic ReviewEmilia Malik, Michał Wizner, Julia I Karpierz, et al.Neurology and Therapy|April 27, 2026
Treatment Characteristics and Healthcare Resource Utilization Among Patients with Myasthenia Gravis Initiating Rozanolixizumab: A US Claims Database AnalysisMohita Kumar, Alexandria Harrold, Minjee Park, et al.Neurology and Therapy|May 6, 2026
Predictive Factors for Non-response to First Use of Polyvalent Intravenous Immunoglobulin in Generalised Myasthenia GravisMatthias Dion, Antoine Gavoille, Valérie Chamouard, et al.Neurology and Therapy|May 6, 2026
Treatment Preferences for Subcutaneous Immunoglobulin Among Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Caregivers, and Physicians: A Discrete Choice ExperimentMin Yang, Miriam L Zichlin, Chelsey Fix, et al.Neurology and Therapy|March 28, 2026
Practical Guidance for Initiation and Management of Patients on Once-Nightly Sodium Oxybate for Narcolepsy Treatment: Modified Delphi Panel Consensus RecommendationsMonique Mulvany, Ellen Wermter, Maggie Lavender, et al.Neurology and Therapy|May 14, 2026
Pediatric Radiologically Isolated Syndrome (RIS): A Case with Active Disease 18 Years LaterAngelo Ghezzi, Mattia Pozzato, Pietro Annovazzi, et al.Neurology and Therapy|March 12, 2026
Initial Monotherapy and Further Anti-seizure Medication Regimens in Adult Patients with Epilepsy: A Population-Based, Longitudinal, Retrospective Analysis of German Prescription DataAdam Strzelczyk, Karel Kostev, Nils G Margraf, et al.Neurology and Therapy|March 12, 2026
Atogepant for the Preventive Treatment of Migraine in Japanese Participants: A Phase 3, Open-Label, 52-Week Extension StudyYasuhiko Matsumori, Krisztian Nagy, Akihiro Takahashi, et al.Neurology and Therapy|February 21, 2026
Patient Perceptions of Needs and Expectations Regarding the Current Management of Myasthenia Gravis: A Biopsychosocial StudyFrancisco Javier Campos-Lucas, Elena Cortés-Vicente, Antonio Guerrero-Sola, et al.Pageof 95